Sotatercept in patients with osteolytic lesions of multiple myeloma-Reference-Cited by-同舟云学术

Sotatercept in patients with osteolytic lesions of multiple myeloma

Published:2014-03-21 Issue:6 Volume:165 Page:814-823
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Abdulkadyrov Kudrat M.¹,Salogub Galina N.²,Khuazheva Nuriet K.³,Sherman Matthew L.⁴,Laadem Abderrahmane⁵,Barger Rachel⁴,Knight Robert⁵,Srinivasan Shankar⁵,Terpos Evangelos⁶

Affiliation:

1. Russian Research Institute of Haematology and Blood Transfusion St Petersburg Russia

2. St Petersburg Pavlov State Medical University n.a. I.P. Pavlov St PetersburgRussia

3. Municipal Clinical Hospital n.a. S.P. Moscow Russia

4. Acceleron Pharma Inc. Cambridge MAUSA

5. Celgene Corporation Summit NJ USA

6. Department of Clinical Therapeutics University of Athens School of Medicine Alexandra General Hospital Athens Greece

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.12835

Reference39 articles.

1. Sequential analysis of biochemical markers of bone resorption and bone densitometry in multiple myeloma;Abildgaard N.;Haematologica,2004

2. Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.

3. CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH-DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION

4. Renal Failure with the Use of Zoledronic Acid

5. A soluble activin type II receptor prevents myeloma bone disease [Abstract];Chantry A.;Haematologica,2007

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using Sotatercept in the Care of Patients With Pulmonary Arterial Hypertension;CHEST;2024-09

2. New and Emerging Therapeutic Drugs for the Treatment of Pulmonary Arterial Hypertension: A Systematic Review;Cureus;2024-08-29

3. TGF-β signaling: critical nexus of fibrogenesis and cancer;Journal of Translational Medicine;2024-06-26

4. Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives;Experimental Hematology & Oncology;2024-04-23

5. Beta-Thalassemia: A Pharmacological Drug-Based Treatment;Drugs and Drug Candidates;2024-02-08